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Abstract During 23A2 skeletal myoblast di¡erentiation,
roughly 30% of the population undergoes apoptosis. Further,
constitutive signaling by G12V:H-Ras or Raf:CAAX abrogates
this apoptosis. In this study, we demonstrate an increase in
NFUB activity in myoblasts that have survived and are express-
ing muscle-speci¢c genes. NFUB activity is also elevated in myo-
blasts expressing constitutively active G12V:H-Ras but not
Raf:CAAX. Expression of a dominant negative IUB (IUB-SR)
su⁄cient to eliminate this elevated level of NFUB activity, in
either the 23A2 myoblasts or their G12V:H-Ras-expressing
counterparts, however, does not a¡ect survival. Furthermore,
expression of a constitutively active IUB kinase in 23A2 myo-
blasts does not protect these cells from the apoptosis associated
with di¡erentiation. Since signaling by IUB kinase can abrogate
di¡erentiation, this result demonstrates that abrogated di¡eren-
tiation and abrogated apoptosis are separable phenotypes.
4 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Apoptosis associated with skeletal myoblast di¡erentiation
has been documented in cultures of primary myoblasts [1,2],
in established muscle cell lines [3,4] and in an established
muscle satellite cell line [5]. As is the case with any important
physiological process [6,7], inappropriate myoblast apoptosis
contributes pathologically to muscle degeneration [8^10].
Thus, an understanding of the molecules that coordinately
regulate skeletal myoblast di¡erentiation and apoptosis is crit-
ical to the design of e¡ective therapies.
Constitutive signaling by Ras [11^13], or its downstream
e¡ector kinase Raf [14^17], is su⁄cient to abrogate skeletal
myoblast di¡erentiation. We have reported that either consti-
tutive signaling by Ras [4] or Raf [17] can also abrogate the
apoptosis associated with 23A2 myoblast di¡erentiation. The
signaling molecules downstream of either Ras or Raf respon-
sible for these phenotypes, however, remain elusive [4,14,17^
19]. A candidate for this signaling molecule, known to be
activated by either Ras [20,21] or Raf [22,23] signaling in
¢broblasts, is the transcription factor NFUB. Like constitutive
signaling by either Ras or Raf, constitutive signaling by
NFUB is su⁄cient to inhibit skeletal myoblast di¡erentiation
[10,24,25]. Constitutive NFUB activity, however, is not re-
quired for the Ras-induced di¡erentiation-defective phenotype
[25]. Since signaling through NFUB has been shown to play an
important role in survival in other systems [26^30], we inves-
tigated the contribution of NFUB signaling to the survival of
23A2 myoblasts during di¡erentiation and to the abrogated
apoptotic phenotype of myoblasts expressing constitutively
active G12V:H-Ras or Raf:CAAX.
2. Materials and methods
2.1. Cells and cell culture
All cells were cultured on gelatin-coated plates and maintained in
growth medium (GM), which consists of basal modi¢ed Eagle’s me-
dium (BME), 10% fetal bovine serum (FBS), and a 1% combination
of 10 000 I.U./ml penicillin and 10 000 Wg ml31 streptomycin (1% P/S).
Di¡erentiation was induced by switching cells from GM to di¡eren-
tiation medium (DM), which consists of BME, 1% P/S and 0% FBS.
Cells were incubated at 37‡C in 5% CO2. The growth and di¡erentia-
tion properties of 23A2 myoblasts and the 23A2 derivative expressing
G12V:H-Ras (A2:H-Ras myoblasts) have been reported previously
[4,18].
2.2. Transient transfection and luciferase assay
Equal cell numbers were plated and the next day transfected using
Lipofectamine Plus per manufacturer’s instructions (Gibco BRL). Lu-
ciferase activity was determined using the DLR Dual Luciferase Kit
per manufacturer’s instructions (Promega). Experiments were per-
formed within the linear range of the assay and a background (no
lysate) measurement was taken and subtracted for each experiment.
The activity of Photinus pyralis luciferase encoded by the reporter
plasmid was normalized in each transfection to the activity of Renilla
reniformus luciferase. Transfected G12V:H-Ras is expressed in the
23A2 myoblasts at levels comparable to c-Ras. The activity of Renilla
luciferase in these A2:G12V:H-Ras myoblasts is similar (10% varia-
tion at most) to that assayed from lysates of identically transfected
23A2 myoblasts.
2.3. DNA binding assay
Nuclear extracts were prepared using the NE-PER1 nuclear and
cytoplasmic extraction reagent kit (Pierce) per manufacturer’s instruc-
tions. Protein concentrations were determined using Coomassie Pro-
tein Assay Reagent (Pierce) and samples were stored at 380‡C. DNA-
binding activity was assessed using the EZ-Detect1 NFUB(p65) Tran-
scription Factor Kit (Pierce) per manufacturer’s instructions. Brie£y,
to a streptavidin-coated well loaded with biotinylated NFUB consen-
sus duplex, 7 Wg of each nuclear extract (6 10 Wl) is added along with
50 Wl of binding bu¡er containing poly dI-dC. Where indicated, wild-
type (WT) NFUB competitor duplex or mutant (M) NFUB competitor
duplex (40 pmol) was added prior to the addition of extract. After 60
min at room temperature with mild agitation, wells were washed three
times followed by incubation with 100 Wl of NFUB(p65) primary anti-
body. After 60 min at room temperature with no agitation, wells were
washed three times followed by incubation with 100 Wl of HRP-con-
jugated secondary antibody. After 60 min at room temperature with
no agitation, wells were washed four times. To each well, 100 Wl of
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equal parts luminol/enhancer solution and stable peroxide solution
was added and chemiluminescence was measured using a luminome-
ter. Baseline chemiluminescence, determined by excluding extract, was
subtracted from each value obtained.
2.4. Cytosolic nucleosome enzyme-linked immunosorbent assays
(ELISAs)
DNA fragmentation and nuclear membrane disruption, as moni-
tored by the presence of cytosolic nucleosomes, was used as a marker
for apoptosis. Cytosolic nucleosomes were measured using the Cell
Death Detection ELISA Plus Kit (Roche Diagnostics) per manufac-
turer’s instructions. Transfected cells were switched to fresh GM or
DM for various times. Attached cells were rinsed in phosphate-bu¡-
ered saline and then lysed by incubation in 300 Wl cell lysis bu¡er from
the kit on a rocker for 30 min at room temperature. Samples were
diluted four-fold and 20 Wl of each sample was transferred to a 96-
well, £at-bottomed, streptavidin-coated microtiter plate. Seventy-two
microliters of 1U incubation bu¡er from the kit, and 4 Wl each of
biotin-conjugated anti-histone antibody and peroxidase-conjugated
anti-DNA antibody was added to the lysate in the microtiter plate
and incubated at 4‡C overnight. Following three washes with 300 Wl
of incubation bu¡er, the presence of cytosolic nucleosomes was mea-
sured by adding 100 Wl of the substrate, ABTS. This was incubated in
the microtiter plates for 5^20 min at room temperature prior to as-
sessment of activity using a spectrophotometer at 405 nm. Experi-
ments were performed within the linear range of the assay. Attached
cells from parallel plates were counted and absorbance was normal-
ized to cell number. A background (no lysate) measurement was taken
and subtracted for each experiment.
2.5. Cell morphology assay
Adherent cells round up during the apoptotic process allowing ap-
optosis to be monitored via a cell morphology-based assay [31]. Cul-
tures transiently transfected with plasmid encoding L-galactosidase
and test vector were ¢xed and stained with 5-bromo-4-chloro-3-indol-
yl-L-D-galactopyranoside as described [31]. The transfection e⁄ciency
of 23A2 myoblasts and A2:G12V:H-Ras myoblasts varied by at most
6^7%. Percentage of apoptotic cells for cultures in DM for 3 or 9 h
was determined as follows: (round blue cells divided by the total
number of blue cells)U100. At least 400 cells were scored from du-
plicate plates for each condition in a blind manner. After culture in
DM for 24 h, the majority of apoptotic 23A2 myoblasts had detached
from the plate [4]. For this reason, total cell numbers were also de-
termined for both attached and corresponding detached cells from
parallel plates. Similar to the calculation performed following TU-
NEL analysis [4], the total percentage of apoptotic cells for each plate
after 24 h in DM was calculated as follows:
{[total attached cellsUpercent round/blue cells]+[total detached
cellsUtransfection e⁄ciency]} divided by [total attached cellsU
percent blue cells]+{[total detached cellsUtransfection e⁄ciency]}.
3. Results and discussion
3.1. NFUB activity is elevated in di¡erentiating 23A2 myoblasts
and in myoblasts expressing constitutively active G12V:H-
Ras but not Raf:CAAX
Although apoptosis is initiated concurrent with di¡erentia-
tion, apoptosis occurs within 8^12 h in DM, while di¡erentia-
tion is completed only after 48 h in DM [4]. Others have
reported an increase in NFUB DNA-binding activity after
24 h in DM that is critical to the di¡erentiation of rat L6E9
skeletal myoblasts [32,33]. These reports, however, did not
examine NFUB transcriptional activity and also did not exam-
ine the temporal activation of NFUB. We have analyzed the
transcriptional activation of NFUB in murine 23A2 skeletal
myoblasts using a luciferase reporter construct containing ¢ve
tandem UB sites (pNFUB-Luc). Apoptosis in these myoblasts
is easily measured after 3 h in DM and is essentially complete
after 8^12 h in DM [4]. We, therefore, analyzed the transcrip-
tional activity of NFUB in 23A2 after 3, 9 and 24 h in DM.
We found that the NFUB activity remained constant when
23A2 myoblasts were switched from GM to DM for either
3 or 9 h, but that this activity increased roughly two-fold after
24 h in DM (Fig. 1A). At ¢rst, this increase in NFUB signal-
ing during the di¡erentiation process would appear to contra-
dict the ¢nding that constitutive NFUB activity inhibits di¡er-
entiation [10,24,25]. However, a similar situation has been
reported for the IFN-inducible protein 202 (p202). Expression
of p202 increases during skeletal myoblast di¡erentiation, yet
constitutive expression of p202 inhibits di¡erentiation [34]. In
both cases, it is likely that while NFUB and p202 activity each
play an important role in the di¡erentiation process, the tem-
porally inappropriate activity of either actually abrogates dif-
ferentiation. The role of NFUB signaling in myoblast survival,
however, has not been examined.
Since activated Ras has previously been shown to signal
through NFUB [20,21], we examined the NFUB activity in
A2:G12V:H-Ras myoblasts, which do not di¡erentiate or
undergo apoptosis in DM [4]. We detected a constitutively
elevated NFUB signal in the A2:G12V:H-Ras myoblasts
that is 3.5-fold greater than that observed in 23A2 myoblasts
in either GM or DM for 3 or 9 h (Fig. 1A). We next assessed
the ability of transiently expressed G12V:H-Ras or Raf:
CAAX to activate NFUB signaling. Expression of G12V:H-
Ras, su⁄cient to abrogate di¡erentiation and the associated
apoptosis of 23A2 myoblasts [17], also constitutively activated
NFUB signaling roughly 3.5-fold (Fig. 1B). Although Raf sig-
naling activates NFUB in other systems [22,23], expression of
Raf:CAAX, su⁄cient to abrogate di¡erentiation and the as-
sociated apoptosis of 23A2 myoblasts [17], did not result in
the constitutive activation of NFUB (Fig. 1B).
Classical increases in NFUB-dependent transcription are
mediated through nuclear translocation and subsequent spe-
ci¢c DNA binding [35]. We, therefore, assessed the speci¢c
DNA binding of nuclear NFUB during di¡erentiation. As
previously reported using L6E9 rat myoblasts [32], the speci¢c
DNA binding of p65-containing nuclear NFUB from 23A2
myoblasts cultured in DM for 24 h is increased when com-
pared to that from 23A2 myoblasts cultured in GM (Fig. 1C).
Signaling by Ras, however, does not increase the nuclear
translocation and subsequent speci¢c DNA binding of
NFUB [20]. Ras-induced increases in NFUB-dependent tran-
scription are mediated through the functional activation of the
p65 subunit of nuclear NFUB [20]. Consistent with this pre-
vious report using NIH 3T3 ¢broblasts, the speci¢c DNA
binding of p65-containing nuclear NFUB from A2:G12V:H-
Ras myoblasts, or 23A2 myoblasts transfected with G12V:H-
Ras or Raf:CAAX, was comparable to similarly cultured pa-
rental 23A2 myoblasts (Fig. 1C).
3.2. Constitutive signaling through NFUB is not su⁄cient to
enhance myoblast survival during di¡erentiation
Since constitutive signaling by NFUB is su⁄cient to inhibit
skeletal myoblast di¡erentiation [10,24], we assessed the abil-
ity of NFUB signaling to abrogate the apoptosis associated
with di¡erentiation. NFUB is kept inactive in the cytoplasm
through association with IUB. The IUB kinase (IKK) complex
is composed of one regulatory subunit and two catalytic sub-
units (IKK-1 and IKK-2). IKK-2 is responsible for the spe-
ci¢c phosphorylation of IUB in vivo. This phosphorylation
signals the degradation of IUB, allowing NFUB to translocate
to the nucleus and regulate transcription [35]. To investigate
the possibility that increased NFUB signaling might be su⁄-
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cient to decrease the apoptosis associated with di¡erentiation,
we utilized a constitutively active mutant of IKK-2 (S177E,
S181E:IKK-2) [36]. Since the luciferase reporter assay allows
detection of NFUB activity only in transfected cells, we uti-
lized this assay to determine the amount of the plasmid en-
coding activated IKK-2 (pS177E, S181E:IKK-2) needed to
increase the level of NFUB activity in 23A2 myoblasts, prior
to the induction of di¡erentiation, to at least the level found
in 23A2 myoblasts that have survived the apoptosis associated
with di¡erentiation. We determined that transfection of 50 ng
of the pS177E, S181E:IKK-2 increased the NFUB transcrip-
tional activity to levels greater than that found in 23A2 myo-
blasts that have survived the apoptosis associated with dif-
ferentiation (Fig. 1A) to levels comparable to that found in
A2:G12V:H-Ras myoblasts (Fig. 2A). The assay to detect
p65-containing NFUB DNA-binding activity assesses the en-
tire culture. We reasoned, however, that we might be able to
detect an increase in p65-containing NFUB DNA-binding ac-
tivity following transfection of pS177E, S181E:IKK-2, since
our transfection e⁄ciency is routinely around 50% ([17] and
personal observations). Nuclear extracts from 23A2 myoblasts
transfected with 50 ng of the pS177E, S181E:IKK-2 possessed
increased p65-containing NFUB DNA-binding activity relative
to nuclear extracts from mock transfected 23A2 myoblasts
(Fig. 2B).
We next assessed the e¡ect of this IKK-2-mediated increase
in NFUB activity on the apoptosis associated with 23A2 myo-
blast di¡erentiation. To do this, we ¢rst performed an ELISA,
which measures cytosolic nucleosomes, as an indicator of
DNA fragmentation in the entire culture. With a transfection
e⁄ciency of 50%, we have previously been able to use this
assay to detect a decrease in DNA fragmentation as a con-
sequence of transient transfection of activated G12V:H-
Ras or Raf:CAAX [17]. Transient transfection of pS177E,
S181E:IKK-2, su⁄cient to increase NFUB activity in 23A2
myoblasts comparable to that observed in G12V:H-Ras my-
oblasts (Fig. 2A), did not reduce the DNA fragmentation that
occurs when a culture of myoblasts is induced to di¡erentiate
(Fig. 2C). We next employed a morphology-based assay to
assess the percentage of apoptotic cells [31]. To assess only
transfected cells, an expression vector encoding L-galactosi-
C
Fig. 1. Elevated NFUB activity in di¡erentiating 23A2 myoblasts
and in myoblasts expressing constitutively active G12V:H-Ras but
not Raf:CAAX. A: Equal cell numbers of 23A2 myoblasts or
A2:G12V:H-Ras myoblasts were plated and the next day trans-
fected as described in Section 2, with 1 Wg of the reporter construct
pNFUB-Luc (5U UB sites) from Stratagene and 2 ng of the plasmid
encoding R. reniformus luciferase. B: Equal cell numbers of 23A2
myoblasts were plated and the next day transfected as described in
Section 2, with 1 Wg of pNFUB-Luc, 2 ng of the plasmid encoding
R. reniformus luciferase, and 0.5 Wg of the indicated test plasmids.
The next day, myoblasts were switched from GM to DM for the in-
dicated times prior to the detection of luciferase activity as de-
scribed in Section 2. Shown in each are the average of duplicates
from a single experiment, which are representative of three indepen-
dent experiments. C: Equal cell numbers of 23A2 myoblasts or
A2:G12V:H-Ras myoblasts were plated. The next day, cultures of
23A2 myoblasts were transfected as indicated with 0.5 Wg of either
plasmid encoding G12V:H-Ras or Raf:CAAX. The next day, cul-
tures were switched to DM for the indicated times prior to the
preparation of nuclear extracts and the detection of p65-containing
NFUB DNA-binding activity as described in Section 2. Shown in
each are the average of duplicates.
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dase was transfected with or without pS177E, S181E:IKK-2.
Once again, however, an increase in NFUB activity in 23A2
myoblasts to the level observed in G12V:H-Ras myoblasts
(Fig. 2A), was not su⁄cient to decrease their apoptosis during
di¡erentiation (Fig. 2D). A lesser increase in NFUB activity is
su⁄cient to inhibit di¡erentiation [37]. It is also worthwhile to
note that this increase in NFUB activity did not enhance ap-
optosis, as has been reported in neurons and epithelial cells
[38,39]. We were unable to determine if elevating NFUB ac-
tivity to levels greater than that observed in the A2:G12V:H-
Ras myoblasts a¡ected the survival of 23A2 myoblasts,
since transient transfection of more than 50 ng of pS177E,
S181E:IKK-2 did not result in higher levels of NFUB activity
(Fig. 2A).
3.3. Elevated NFUB transcriptional activity is not required for
the survival of di¡erentiating myoblasts or for the
abrogated apoptotic phenotype of myoblasts expressing
constitutively active G12V:H-Ras
The ¢nding that signaling through NFUB is not su⁄cient to
Fig. 2. Constitutive signaling through NFUB is not su⁄cient to alleviate the apoptosis associated with 23A2 myoblast di¡erentiation. A: Equal
cell numbers were plated and, the next day, transfected with 1Wg of the reporter construct pNFUB-Luc, 2 ng of the plasmid encoding R. reni-
formus luciferase and the indicated amount of the plasmid encoding constitutively active IKK-2 (pS177E,S181E:IKK-2, a gift from Frank Mer-
curio). The next day, myoblasts were switched from GM to DM for 3 or 9 h prior to the detection of luciferase activity. Shown in each are
the average of duplicates from a single experiment, which are representative of three independent experiments. B: Equal cell numbers were
plated and, the next day, transfected with the indicated amount of pIKK-2. Nuclear extracts were prepared the next day and p65-containing
NFUB DNA-binding activity was determined. Shown in each are the average of duplicates. C: Equal cell numbers were plated and the next
day transfected with the indicated amount of pIKK-2. On the third day, myoblasts were switched to DM. After either 3 or 9 h, cytosolic nucle-
osomes were detected using Cell Death Detection ELISA Plus Kit (Roche Diagnostics) per manufacturer’s instructions as described in Section
2. Shown in each are the average of duplicates from a single experiment, which are representative of three independent experiments. D: Eual
cell numbers were plated and the next day transfected with the indicated amount of pIKK-2 and 1 Wg of the plasmid encoding L-galactosidase.
On the third day, after culture in DM for either 3 or 9 h, cells were stained for L-galactosidase as described in Section 2. Apoptotic cells were
scored and the percentage of apoptotic cells was calculated as described in Section 2. Shown are the averages from duplicate plates for each
condition.
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increase myoblast survival during the di¡erentiation process
does not eliminate the possibility that signaling through
NFUB may still be necessary for the survival of the roughly
70% of myoblasts that do complete the process of di¡erentia-
tion. To investigate this possibility, we utilized a dominant
negative form of IUB that cannot be phosphorylated (IUB-
SR) and thus is not targeted for degradation by IKK-medi-
ated signaling [35,40]. Again, since the luciferase reporter as-
say allows detection of NFUB activity in only transfected cells,
we utilized this assay to determine that the inhibition of
NFUB activity by IUB-SR was dose dependent (Fig. 3A).
Transfection of 10 ng of the plasmid encoding IUB-SR
(pIUB-SR) was su⁄cient to prevent the increase in NFUB
activity normally observed in 23A2 myoblasts that have sur-
vived the apoptosis associated with di¡erentiation (Fig. 3A).
A decrease in p65-containing NFUB DNA-binding activity is
also achieved with transfection of 10 ng of pIUB-SR (Fig. 3B).
Preventing the increase in NFUB activity that occurs during
Fig. 3. Inhibition of NFUB activity does not alter the survival of 23A2 myoblasts or A2:G21V:H-Ras myoblasts. A: Equal cell numbers
were plated and the next day transfected with 1 Wg of the reporter construct NFUB-Luc, 2 ng of the plasmid encoding R. reniformus lu-
ciferase and the indicated amount of the plasmid encoding IUB-SR (pIUB-SR, a gift from Dr. K. Brand, Munich, Germany). The next day,
myoblasts were switched from GM to DM for 24 h, or, as indicated, prior to the detection of luciferase activity. Shown in each is the average
of duplicates from a single experiment, which are representative of three independent experiments. B: Equal cell numbers were plated and, the
next day, transfected with the indicated amount of pIkB-SR. The next day, myoblasts were switched to DM for the indicated times prior to
the preparation of nuclear extracts and the determination of p65-containing NFUB DNA-binding activity. Shown in each is the average of du-
plicates. C: Equal cell numbers were plated and, the next day, transfected with the indicated amount of pIkB-SR. The next day, myoblasts
were switched to DM for the indicated times prior to the detection of cytosolic nucleosomes using Cell Death Detection ELISA Plus Kit.
Shown in each is the average of duplicates from a single experiment, which are representative of three independent experiments. D: Equal cell
numbers were plated and the next day transfected with the indicated amount of pIUB-SR and 1 Wg of the plasmid encoding L-galactosidase.
On the third day, cultures were switched to DM for the indicated times. Cells were then stained for L-galactosidase. Apoptotic cells were
scored and the percentage of apoptotic cells was calculated as described in Section 2. Shown are the averages from duplicate plates for each
condition.
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di¡erentiation, however, failed to increase the amount of
DNA fragmentation (Fig. 3C) or the apoptosis of these my-
oblasts (Fig. 3D). As reported previously [4], although the
¢nal percentage of apoptotic myoblasts is determined between
8 and 12 h of culture in DM, the DNA fragmentation per
apoptotic cell continues to increase with time in DM (Fig.
3C,D).
Since IUB can relocate NFUB from the nucleus into the
cytosol [41], and has been previously used to decrease
NFUB activity to determine the signi¢cance of NFUB signal-
ing in Ras-mediated phenotypes in ¢broblasts [20,42], we em-
ployed this same strategy to decrease NFUB activity and as-
sess the contribution of NFUB signaling to the abrogated
apoptosis observed in A2:G12V:H-Ras myoblasts. Using
the luciferase reporter assay to assess NFUB activity in only
transfected cells, a reduction of the constitutively elevated
NFUB activity in A2:G12V:H-Ras myoblasts, to a level
slightly less than that found in parental 23A2 myoblasts still
in the process of undergoing the apoptosis associated with
di¡erentiation, was also achieved with 10 ng of pIUB-SR
(Fig. 3A). Furthermore, a decrease in the basal p65-contain-
ing NFUB DNA-binding activity detected in nuclear extracts
of A2:G12V:H-Ras myoblasts could be observed with 10 ng
of pIUB-SR (Fig. 3B). Once again, however, this reduction in
NFUB activity did not a¡ect the abrogated apoptosis observed
in A2:G12V:H-Ras myoblasts (Fig. 3C,D).
3.4. Conclusions
Although NFUB transcriptional activity is elevated in myo-
blasts that have survived and are in the process of expressing
muscle-speci¢c genes, abrogation of this activity does not af-
fect survival. Furthermore, although apoptosis is induced fol-
lowing abrogation of elevated NFUB transcriptional activity
in ¢broblasts expressing a constitutively active Ras [42], ele-
vated NFUB transcriptional activity is not necessary to main-
tain the survival of 23A2 myoblasts expressing constitutively
active Ras. Finally, constitutive signaling through NFUB is
not su⁄cient to protect myoblasts from the apoptosis associ-
ated with di¡erentiation.
Since both di¡erentiation and the associated apoptosis are
induced by the same culture conditions, and both can be
abrogated by culture in fresh serum or by expression of con-
stitutive active Ras [4] or Raf [17] signaling, the question
arises as to whether these processes can be separated. NFUB
signaling now represents a pathway capable of inhibiting dif-
ferentiation without inhibiting the associated apoptosis. De-
spite advances which minimize immune responses [43,44],
myoblast therapy as an approach to the treatment of inherited
muscular dystrophies is still severely impaired by the poor
survival of transplanted myoblasts [45,46]. Identi¢cation of a
signaling pathway(s) that does not a¡ect di¡erentiation but
that does inhibit the apoptosis associated with di¡erentiation
should prove useful. Demonstrating that abrogated di¡eren-
tiation and abrogated apoptosis are separable phenotypes is
an important step toward this goal. The search for such can-
didate pathways is ongoing.
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